London Vision Clinic, London, UK.
J Refract Surg. 2012 Aug;28(8):531-41. doi: 10.3928/1081597X-20120723-01.
To evaluate the monocular and binocular visual outcomes of LASIK with an aspheric micro-mono-vision protocol in emmetropic patients with presbyopia.
A retrospective, noncomparative case series included 296 eyes from 148 consecutive emmetropic patients with presbyopia who were treated with LASIK-induced micro-monovision. The CRS-Master software was used to generate ablation profiles for the MEL 80 excimer laser (Carl Zeiss Meditec) and flaps were created using the VisuMax femtosecond laser (Carl Zeiss Meditec). The target refraction was plano for distance eyes (dominant eye) and between -1.00 and -1.88 diopters (D) for near eyes. Patients were followed for 1 year. Emmetropia was defined for inclusion as spherical equivalent refraction ⩾- 0.88 D, sphere ⩽+1.00 D, and cylinder ⩽1.25 D. Median patient age was 55 years (range: 44 to 65 years). Median follow-up was 12.9 months.
Mean deviation from intended correction was +0.02±0.35 D, with 91% within ±0.50 D and 100% within ±1.00 D. Of distance eyes, 95% achieved uncorrected distance visual acuity (UDVA) of 20/20 or better and 100% achieved 20/32 or better. Binocularly, 98% of patients achieved UDVA of 20/20 or better and 100% achieved 20/32 or better; 96% achieved uncorrected near visual acuity of J2 and 99% could read J3 or better. No eyes lost 2 or more lines of corrected distance visual acuity. An average increase of 0.05 logMAR was noted in distance-corrected near visual acuity. A small increase occurred in mesopic contrast sensitivity (CSV-1000, VectorVision Inc) at 3 cycles per degree (cpd) (P=.016) and no change at 6, 12, or 18 cpd.
This aspheric micro-monovision protocol was a well-tolerated and effective procedure for treating emmetropic patients with presbyopia.
评估在老视的正视患者中应用微单视准分子激光角膜切削术的离焦量方案的单眼和双眼视觉效果。
回顾性非对照病例系列研究纳入了 148 例老视正视患者的 296 只眼,这些患者接受了微单视准分子激光角膜切削术治疗。使用 CRS-Master 软件为 MEL 80 准分子激光(卡尔蔡司公司)生成消融曲线,并使用 VisuMax 飞秒激光(卡尔蔡司公司)制作角膜瓣。距离眼(主导眼)的目标屈光度为正视,近距眼的目标屈光度为-1.00 至-1.88 屈光度(D)。患者随访 1 年。纳入标准为等效球镜屈光度≥-0.88 D,球镜≤+1.00 D,柱镜≤1.25 D。中位患者年龄 55 岁(范围:44 至 65 岁)。中位随访时间为 12.9 个月。
平均与预期矫正值的偏差为+0.02±0.35 D,91%在±0.50 D 以内,100%在±1.00 D 以内。95%的距离眼未矫正远视力(UDVA)达到 20/20 或更好,100%达到 20/32 或更好。双眼患者 98%达到 20/20 或更好的 UDVA,100%达到 20/32 或更好;96%达到未矫正近视力 J2,99%可阅读 J3 或更好。无 2 行或更多行矫正远视力丧失。远距矫正近视力平均增加 0.05 logMAR。在 3 周/度(cpd)时,中值对比敏感度(CSV-1000,VectorVision Inc)略有增加(P=.016),在 6、12 和 18 cpd 时无变化。
这种非球面微单视准分子激光角膜切削术方案是一种治疗老视正视患者的安全且有效的方法。